Defining the Future of MIDD: Lessons Learned, Remaining Challenges & Emerging Opportunities

4:30 pm - Thursday 19th November 2026

A moderated panel drawing on speakers from across both conference days to share honest retrospective experience of MIDD implementation.

  • Where has MIDD genuinely changed a development decision, and where has it been used to validate a decision that had already been made?
  • What has been the hardest internal sell for MIDD, and what argument finally worked?
  • Where have you seen the field overclaim what modelling can do, and what are the consequences of that for regulatory trust?

Speakers:

Director - Clinical Pharmacology & Pharmacology
Abbvie
Global Head of Pharmacometrics/Quantitative Pharmacology
Sanofi
Associate Director - Clinical & Quantitative Pharmacology
Vertex Pharmaceuticals